Big Data A $4 Billion Opportunity in the Healthcare and Pharmaceutical Industry; Finds New Report

latest report indicates that Big Data investments in the healthcare and pharmaceutical industry are expected to reach nearly $4 Billion by the end of 2017.

Originally used as a term to describe datasets whose size is beyond the ability of traditional databases, the scope of Big Data has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.

Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.

Publisher estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone.  Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.

The “BIG DATA IN THE HEALTHCARE & PHARMACEUTICAL INDUSTRY: 2017 – 2030 – OPPORTUNITIES, CHALLENGES, STRATEGIES & FORECASTS” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.

Spanning over 499 pages “Big Data in the Healthcare & Pharmaceutical Industry: 2017 - 2030 - Opportunities, Challenges, Strategies & Forecasts” report covers Introduction, An Overview of Big Data, Big Data Analytics, Business Case & Applications in the Healthcare & Pharmaceutical Industry, Healthcare & Pharmaceutical Industry Case Studies, Future Roadmap & Value Chain, Standardization & Regulatory Initiatives, Market Analysis & Forecasts, Vendor Landscape. This report Covered 339 Companies few are - 1010data, Absolutdata, Accenture, ACR (American College of Radiology), Actian Corporation, Adaptive Insights, Advizor Solutions, AeroSpike, Aetna, AFS Technologies, Alation, Algorithmia, Alluxio, Alphabet, Alpine Data.

Please visit this link for more details: http://mrr.cm/U6M

Find all Big Data Reports at: http://www.marketresearchreports.com/big-data